SNORD18C: A Potential Drug Target and Biomarker (G595100)

Target Name: SNORD18C

NCBI ID: G595100

SNORD18C

Other Name(s): Small nucleolar RNA, C/D box 18C | small nucleolar RNA, C/D box 18C | U18C

SNORD18C: A Potential Drug Target and Biomarker

Small nucleolar RNA (snRNA) is a class of non-coding RNAs that play a critical role in various cellular processes, including DNA replication, gene expression, and RNA processing. One of the most well-known snRNAs is SNORD18C, which is located in the C/D box region of RNA molecules. The functions of SNORD18C and its potential as a drug target or biomarker are the focus of this article.

SNORD18C: Structure and Function

The C/D box region of RNA molecules is a common structural feature that is present in many proteins, including snRNAs. It is a conserved region that is involved in the formation of double bonds between the C and D nucleotides of the RNA molecule. SNORD18C is a 24-nt RNA molecule that has a unique structure, consisting of a single open reading frame (ORF) and a single exonic region.

The exonic region of SNORD18C is composed of a single exon that starts at the 5' end of the RNA molecule and ends at the 3' end. The ORF of SNORD18C is composed of four exons that are involved in the formation of a stem-loop structure. The stem-loop is a common structural motif that is found in many RNA molecules and is involved in the regulation of gene expression.

The functions of SNORD18C are still not well understood, but its unique structure and the fact that it is located in the C/D box region suggest that it plays an important role in the regulation of gene expression. It is possible that SNORD18C is involved in the formation of RNA molecules that are involved in cellular processes such as DNA replication, transcription, or translation.

Drug Target Potential

SNORD18C has been identified as a potential drug target due to its unique structure and the functions that it is involved in. The C/D box region is a known drug target for small nucleolar RNA (snRNA) viruses, and SNORD18C may be vulnerable to similar mechanisms of inhibition.

One of the potential strategies for targeting SNORD18C is to inhibit the activity of the C/D box region, which would result in the inhibition of the formation of RNA molecules that are involved in cellular processes. This could be done using small molecule inhibitors or RNA interference therapies.

Biomarker Potential

SNORD18C may also be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and genetic disorders. The functions of SNORD18C are not well understood, but its unique structure and the fact that it is located in the C/D box region suggest that it may be involved in the regulation of gene expression.

Considering the potential drug target and biomarker properties of SNORD18C, future studies are needed to better understand its functions and develop effective therapies. In addition, there is a need for further research into the mechanisms of inhibition of the C/D box region and the regulation of gene expression by SNORD18C.

Conclusion

SNORD18C is a unique small nucleolar RNA molecule that is located in the C/D box region and has been identified as a potential drug target and biomarker. The functions of SNORD18C are not well understood, but its unique structure and the fact that it is involved in the regulation of gene expression suggest that it plays an important role in cellular processes. Further studies are needed to better understand its functions and develop effective therapies.

Protein Name: Small Nucleolar RNA, C/D Box 18C

The "SNORD18C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD18C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets